Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.

Ohad Atia Ramit Magen RimonNatan LeddermanShira GreenfeldRevital KarivYiska Loewenberg WeisbandRon ShaoulEran MatzShmuel OdesIdan GorenHenit YanaiIris DotanDan Turner

Published in: Inflammatory bowel diseases (2023)

Nowadays, 18% of patients with UC do not receive maintenance therapy, of whom half remain without treatment after 3 years. Matched pairs of patients on NMT and 5-aminosalicylic acid, representing the mildest patients of the latter, had similar outcomes. Prospective studies are needed to further explore the role of NMT in UC.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
ulcerative colitis
prognostic factors
peritoneal dialysis
type diabetes
metabolic syndrome
bone marrow
patient reported outcomes
replacement therapy
cell therapy